Drugs / Arnica
Trials 4
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT05283434 | Jul 2021 → Jun 2023 | — | Children's Hospitals and Clinics of Minnesota | Unknown | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT00774293 | Sep 2004 → Jun 2007 | aortic valve disorder | BOIRON | Completed | No outcome recorded |
| Phase not applicable2 trials | ||||||
| — | NCT07162454 | Nov 2024 → May 2025 | diabetic polyneuropathy | Universidad Complutense de Madrid | Completed | No outcome recorded |
| — | NCT00363038 | Jul → Aug 2006 | — | Northwestern University | Completed | No outcome recorded |
| Comparator or background therapy2 trials | ||||||
| — | NCT03520595 Comparator | Dec 2016 → Jan 2017 | — | Tatyasaheb Kore Dental College | Completed | No outcome recorded |
| — | NCT01598909 Comparator | Jan 2013 → Jan 2014 | eyelid disorder | Wynand BWH Melenhorst, MD | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Arnica | “received a topical cream with cannabidiol, Urea 10%, arnica and menthol as active ingredients” NCT07162454 ↗ |
| Known as | Arnica Montana | “Homeopathic Arnica Montana is a well-established complimentary medicine and may provide a good alternative for managing acute pain from musculoskeletal injuries, especially in...” NCT05283434 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Arnica 5CH and Bryonia 9CH (homeopathic drugs)” NCT00774293 ↗ |
| Route | Topical | “Application of Arnica ointment periorbitally” NCT01598909 ↗ |